Form 8-K - Current report:
SEC Accession No. 0001213900-14-007787
Filing Date
2014-11-06
Accepted
2014-11-06 07:05:55
Documents
3
Period of Report
2014-11-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ACTINIUM PHARMACEUTICALS, INC. FORM 8-K f8k110614_actiniumpharma.htm 8-K 14182
2 EXHIBIT 99.1 f8k110614ex99i_actiniumphar.htm EX-99.1 17259
3 GRAPHIC logo.jpg GRAPHIC 4087
  Complete submission text file 0001213900-14-007787.txt   38391
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 141198754
SIC: 2834 Pharmaceutical Preparations